Efficacy of sequencing of cytotoxic and endocrine therapies in veterans with metastatic castration-resistant prostate cancer (mCRPC). This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback